Guilin Sanjin Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000DY9
CNY
15.28
0.06 (0.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
520.95
461.11
605.62
500.33
573.11
477.69
526.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
520.95
461.11
605.62
500.33
573.11
477.69
526.30
Raw Material Cost
146.79
112.11
197.00
136.06
154.70
133.32
168.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
4.54
5.65
2.80
2.34
3.05
0.00
Selling and Distribution Expenses
158.77
193.35
276.27
232.71
167.55
204.22
297.89
Other Expenses
1.89
3.02
4.82
2.84
3.77
2.42
4.62
Total Expenditure (Excl Depreciation)
324.49
340.21
527.09
399.97
362.31
364.74
512.90
Operating Profit (PBDIT) excl Other Income
196.5
120.9
78.5
100.39999999999999
210.79999999999998
112.89999999999999
13.4
Other Income
11.89
12.97
129.01
14.53
18.73
17.30
37.41
Operating Profit (PBDIT)
234.96
160.49
218.68
147.02
257.58
158.30
71.51
Interest
0.00
4.54
5.65
2.80
2.34
3.05
0.00
Exceptional Items
3.74
0.42
3.06
0.83
0.75
0.00
2.03
Gross Profit (PBDT)
374.16
349.00
408.63
364.27
418.41
344.36
357.54
Depreciation
26.61
26.61
35.19
35.19
28.05
28.05
31.69
Profit Before Tax
212.09
129.76
180.90
109.86
227.94
127.19
41.84
Tax
30.09
24.94
41.29
26.95
26.98
27.18
16.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
182.01
104.82
137.66
82.90
200.95
100.02
24.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
182.01
104.82
137.66
82.90
200.95
100.02
24.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
182.01
104.82
137.66
82.90
200.95
100.02
24.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,130.01
3,132.78
3,009.78
3,014.14
2,932.72
2,907.76
2,816.96
Earnings per share (EPS)
0.31
0.18
0.23
0.14
0.34
0.17
0.04
Diluted Earnings per share
0.31
0.18
0.23
0.14
0.34
0.17
0.04
Operating Profit Margin (Excl OI)
37.71%
26.22%
8.99%
19.45%
36.78%
23.64%
0.46%
Gross Profit Margin
45.82%
33.91%
35.68%
28.99%
44.67%
32.5%
13.97%
PAT Margin
34.94%
22.73%
22.73%
16.57%
35.06%
20.94%
4.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 12.97% vs -23.86% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 73.66% vs -23.89% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 51.25% vs 64.44% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -100.00% vs -19.64% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Guilin Sanjin Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
520.95
0
520.95
Other Operating Income
0.00
0.00
0.00
Total Operating income
520.95
0
520.95
Raw Material Cost
146.79
0
146.79
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
158.77
0
158.77
Other Expenses
1.89
0.00
1.89
Total Expenditure (Excl Depreciation)
324.49
0
324.49
Operating Profit (PBDIT) excl Other Income
196.46
0.00
196.46
Other Income
11.89
0
11.89
Operating Profit (PBDIT)
234.96
0
234.96
Interest
0.00
0
0.00
Exceptional Items
3.74
0
3.74
Gross Profit (PBDT)
374.16
0
374.16
Depreciation
26.61
0
26.61
Profit Before Tax
212.09
0
212.09
Tax
30.09
0
30.09
Provisions and contingencies
0
0
0.00
Profit After Tax
182.01
0
182.01
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
182.01
0
182.01
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
182.01
0
182.01
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,130.01
0
3,130.01
Earnings per share (EPS)
0.31
0
0.31
Diluted Earnings per share
0.31
0
0.31
Operating Profit Margin (Excl OI)
37.71%
0%
0.00
37.71%
Gross Profit Margin
45.82%
0%
0.00
45.82%
PAT Margin
34.94%
0%
0.00
34.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 52.09 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 12.97% vs -23.86% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -9.11% vs 22.38% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 18.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 73.66% vs -23.89% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -9.45% vs -4.42% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.31 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 51.25% vs 64.44% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -6.57% vs 0.72% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.71%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024